Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The study was conducted as an open label, balanced, randomised, two-treatment, two-period, two-sequence, single-dose crossover bioavailability study on fenofibrate formulations comparing fenofibrate 160 mg tablets of Ranbaxy Laboratories with Tricor 160 mg tablets in healthy, adult, human subjects under fasting conditions.
Epistemonikos ID: 764baa9c580acc7eb9fc29802ffcb7ae3544aa2b
First added on: May 05, 2024